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Abstract
Background: Serum amyloid A protein (SAA) is not only an inflammatory factor, but also an apolipoprotein that can replace
apolipoprotein A1 (apoA1) as the major apolipoprotein of high-density lipoprotein (HDL), which has been linked to
atherosclerosis. However, the relationship between genetic polymorphisms of SAA and the intima-media thickness (IMT) of
the common carotid artery in healthy subjects remains unclear. We investigated the role of SAA1 and SAA2 gene
polymorphisms with IMT in a cohort of healthy subjects participating in the Cardiovascular Risk Survey (CRS) study.
Methodology/Principal Findings: Anthropometric and B-mode ultrasound of the carotid IMT were measured in 1914
subjects (849 men; 1065 women) recruited from seven cities in Xinjiang province, (western China). Four SNPs (rs12218,
rs2229338, rs1059559, and rs2468844) were genotyped by use of the polymerase chain reaction-restriction fragment length
polymorphism (PCR-RFLP) method. The SNP rs12218 was associated with carotid IMT by analyses of a dominate model
(P,0.001) and additive model (P=0.003), and the difference remained significant after multivariate adjustment (P=0.008,
P,0.001, respectively). This relationship was also observed in rs2468844 after multivariate adjustment by recessive model
analysis (P=0.011) but this was not observed in rs2229338 and rs1059559 before and after multivariate adjustment. These
associations were not modified by serum HDL concentration. Furthermore, there were significant interactions between
rs2468844 and rs12218 (interaction P,0.001) and rs2229338 (interaction P=0.001) on carotid IMT.
Conclusion/Significance: Both rs12218 of the SAA1 gene and rs2468844 of SAA2 gene are associated with carotid IMT in
healthy Han Chinese subjects.
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Introduction
Inflammation is a key process in the pathogenesis of
atherosclerosis (AS). Accumulated evidences suggest that several
environmental risk factors for cardiovascular disease (CVD; e.g.,
smoking, obesity and alcohol) may act by promoting inflamma-
tion. Moreover, many epidemiological studies have confirmed that
levels of high density lipoproteins (HDL) have a strong inverse
relationship with atherosclerosis and coronary artery disease
(CAD). In general, a low level of high-density lipoprotein-
cholesterol (HDL-C) in plasma is accepted as being a strong and
independent risk factor for the development of premature
atherosclerosis.
Serum amyloid A (SAA) is not only one of the acute phase
proteins, but also a kind of apolipoprotein. SAA is primarily
synthesized in the liver by activated monocytes and macrophages
[1]. Studies [2] have shown that in vivo concentrations of SAA in
plasma can be dramatically increased (up to 1000-fold) during
acute inflammatory conditions [3]. As an apolipoprotein, SAA is
associated with HDL and during inflammation can contribute up
to 80% of its apoprotein composition [3]. Many studies have
demonstrated that sustained high expression of SAA may
contribute to atherogenesis [4,5], and that an elevated concentra-
tion of SAA is associated with an increased risk of CVD [6].
However, the relationships between SAA gene polymorphisms and
carotid atherosclerosis remain unclear.
The human SAA gene cluster on the short arm of chromosome
11, localized to band p15.1, contains four related genes, SAA1-4,
within a 150-kb region [7]. Only the SAA1 and SAA2 genes encode
acute-phase SAAs (SAA1 and SAA2 proteins), so a lot of research
focuses on them. Recently, Carty et al. [8] reported an association
of SAA1 and SAA2 gene polymorphisms and carotid intima-media
thickness (cIMT), HDL, and total CVD. However, the relation-
ship between the genetic polymorphisms of SAA1/2 and carotid
cIMT and HDL level in healthy subjects is incompletely
understood.
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13997The aim of the present study was to explore the relationship
between SAA1/2 gene polymorphisms and cIMT as well as HDL
levels in plasma in healthy subjects participating in the
Cardiovascular Risk Survey (CRS).
Results
Characteristics of study participants
The study cohort consists of 1914 subjects (849 men; 1065
women). The clinical and metabolic characteristics of the study
population are shown separately for men and women in Table 1.
SAA1/2 genotype and allele frequencies
All genotyped SNPs were in Hardy-Weinberg equilibrium and
common with minor allele frequencies .0.05. Table 2 shows
detailed information for each SNP as well as the allele frequencies.
Associations with baseline IMT and HDL level
Using general linear model analysis, rs12218 was found to be
significantly associated with serum HDL levels in a dominate
model or additive model before (P,0.001, P,0.001, respectively)
and after multivariate adjustment (P=0.003, P=0.011, respec-
tively). Also, rs2468844 was significantly associated with serum
HDL levels in a dominate model or additive model before
(P,0.001, P,0.001, respectively) and after multivariate adjust-
ment (P=0.003, P=0.011, respectively, Table 3).
As shown in Table 4, rs12218 was associated with cIMT in a
dominate model or additive model before (P,0.001, P=0.003,
respectively) and after multivariate adjustment (P=0.008,
P,0.001, respectively). However, rs2468844 was associated with
cIMT only in a recessive model after multivariate adjustment
(P=0.011). These associations were not found in rs2229338 and
rs1059559 before and after adjustment of key co-variants.
Significant interactions were observed between rs2468844 and
rs12218 (interaction P,0.001) and rs2229338 (interaction
P=0.001) on carotid IMT (Table 5).
Discussion
We found that variation in the SAA1 and SAA2 genes is
associated with the IMT of the common carotid artery in healthy
Han Chinese subjects. These associations were not modified by the
HDL concentration in serum. Furthermore, there were significant
interactions between SAA1 and SAA2 on cIMT. This was the first
study investigating common allelic variants in SAA1 and SAA2
genes and their association with IMT in Han Chinese subjects.
The foundation for human studies examining putative causative
genes that may be involved in cIMT is based on a candidate gene
approach. This involves selecting a functionally relevant gene to
study and subsequently investigating its association with carotid
atherosclerosis. The genes for SAA1and SAA2 are candidates for
atherosclerosis because they are the genes encoding one important
inflammation factor, SAA, which is synthesized by the liver [9].
Plasma SAA levels, serum HDL concentration and carotid
IMT
In the early 1970s, SAA was identified as the plasma protein
responsible for forming tissue deposits called ‘‘amyloid (AA-type)’’
seen in diseases with underlying persistent acute inflammation
[10,11]. Soon after its discovery, SAA was shown to be an acute-
phase protein produced by the liver within hours of tissue injury
regardless of cause. Its plasma concentration can increase a 1000-
fold within 24 h [12,13]. In plasma, SAA is associated with HDL
[14,15] and, during severe inflammation, can contribute #80% of
its apo-protein composition [16,17]. The displaced apoA-I is
rapidly cleared by the liver and kidneys [18], together with a sharp
decline in apoA-I gene expression during inflammation [19].
O’Brien et al. [20] demonstrated that SAA accumulates in
atherosclerotic lesions of apoE2/2 and LDLR2/2 mice and
suggested that SAA might play a part at each stage of lesion
development. Johnson et al. [6] reported a strong independent
relationship between SAA and future cardiovascular events. They
indicated that systemic inflammation, as manifested by high SAA
levels, may promote destabilization of atherosclerotic plaque, in
addition to exerting a possible direct effect on atherogenesis. IMT
can be used as an independent surrogate marker of atherosclerosis
[21]. Therefore, elevated levels of SAA and decreased concentra-
tions of HDL are positively associated with IMT (just as with
atherosclerosis).
Table 1. Demographic and risk profile of the study
population.
Risk factor No. (%) or Mean (SD)
Total cohort Men Women
Never drink (%) 1556 (80.4) 528 (60.9) 1028 (96.0)
Former drinker (%) 82 (4.2) 68 (7.9) 14 (1.3)
Current drinker (%) 276 (14.3) 253 (29.4) 23 (2.1)
Never smoking (%) 1380 (71.3) 319 (37.0) 1058 (98.8)
Former smoking (%) 131 (6.8) 127 (14.7) 4 (0.4)
Current smoking (%) 422 (21.8) 415 (48.1) 7 (0.7)
Age (years) 48.34 (11.99) 49.19 (13.38) 47.65 (10.72)
BMI (kg/m
2) 24.01 (3.24) 24.62 (2.80) 23.50 (3.48)
SBP(mmHg) 127.5 (17.0) 129.24 (15.59) 126.32 (17.90)
DBP(mmHg) 77.9 (12.0) 79.97 (12.33) 76.42 (11.59)
Uric acid (mmol/L) 298.5 (83.8) 346.36 (81.16) 260.32 (63.75)
Glucose (mmol/L) 5.03 (1.17) 5.17 (1.33) 4.93 (1.01)
Triglyceride (mmol/L) 1.46 (1.17) 1.73 (1.40) 1.25 (0.89)
TC (mmol/L) 4.54 (0.92) 4.55 (0.93) 4.54 (0.92)
HDL –C (mmol/L) 1.40 (0.40) 1.28 (0.38) 1.50 (0.39)
LDL-C (mmol/L) 2.88 (0.88) 2.93 (0.90) 2.83 (0.85)
Note: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; HDL, high-density lipoprotein; LDL, high-density lipoprotein; TC, total
cholesterol.
doi:10.1371/journal.pone.0013997.t001
Table 2. Genotypes and alleles distribution of study subjects.
SNPs n Genotype (%)
Allele
(frequency)
rs12218 1914 TT CT CC T C
1050 (54.9) 734 (38.3) 130 (6.8) 0.74 0.26
rs2229338 1912 AA AG GG A G
1583(82.8) 313 (16.4) 16 (0.8) 0.91 0.09
rs1059559 1910 TT CT CC T C
1348 (70.6) 513 (26.9) 49 (2.5) 0.84 0.16
rs2468844 1914 AA AG GG A G
1520 (83.4) 369 (15.8) 25 (0.08) 0.89 0.11
doi:10.1371/journal.pone.0013997.t002
SAA Gene and IMT
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concentrations
Increasing evidence suggests that inflammation is important in
the pathogenesis of atherosclerosis, stroke, and ischemic heart
disease. In prospective studies, elevated basal levels of SAA were
shown to be predictive of future vascular events [6]. In 2000,
Yama et al. [22] reported that the SAA1 allele influences the
plasma concentration of SAA. In the Japanese population, subjects
with the SAA1.5 allele have a higher plasma concentration of SAA
than those lacking this allele. In the present study, we did not
examine the SAA levels between each genotype, which was a
limitation of our analysis. We can consider that this SNP may be
associated with the tagging SNP we selected in the present study,
although we could not identify the rs number of the SAA1.5
polymorphism described by Yama et al [22]. In the present study,
we also found that the SAA1/2 polymorphisms were associated
with the serum concentration of HDL. This result was in
accordance with the finding reported by Carty et al. [8].
In addition, SAA is secreted into plasma, where it associates
primarily with HDL particles but also with very-low-density
lipoprotein (VLDL) particles [13]. SAA has been shown to
mediate the binding of HDL to differentiated macrophages and
endothelial cells [23] and to impair the ability of HDL to promote
cholesterol efflux from macrophages [24].
SAA1/2 genetic polymorphisms and cIMT
Carty et al. [8] reported that SAA2 SNPs were associated with
increased IMT in African-American subjects, but this association
was not observed in European- American subjects. In the present
study, we found not only SAA2 SNP (rs2468844) but also SAA1
SNP (rs12218) was associated with increased IMT in Han Chinese
subjects after adjustment for age, sex, and other factors. These two
genes also had significant interactions with cIMT. SAA also has
the propensity to affect the concentration and composition of
HDL, so we also examined whether the relationship between SAA
genetic variants and IMT is modified by HDL concentration.
There was a strong association between rs12218 and rs2468844
and circulating levels of HDL, but the serum level of HDL was not
an independent predictor of cIMT and did not modify the
relationship between SAA genetic variants and IMT. Carty et al.
investigated the relationship between SAA gene SNPs and HDL
levels and IMT in disease states, particularly in subjects with CVD
[8]. The population in the present study was a large healthy
cohort, so we could evaluate relationships independent of the
potentially confounding secondary effects of the disease. However,
the present study was cross-sectional; the CRS study is a
multicenter study, and we can investigate a large and well-
characterized healthy population.
The mechanisms which may link SAA1/2 genetic polymor-
phisms to carotid atherosclerosis are largely unknown. However, it
is accepted that SAA can generate HDL using cellular lipids, a
function mediated by the ATP-binding cassette transporter
proteins ABCA1 or ABCA7. In addition, in the inflammatory
state, HDL composition is altered because its apoA-I and apoA-II
components are displaced by SAA in the form of predominately
SAA protein. ApoA-I plays an important part in reverse
cholesterol transport and therefore may be protective against
atherosclerosis, so its displacement by SAA is considered to be
potentially pro-atherosclerotic. Carty et al. [8] indicated that
variation in SAA1/SAA2 could lead to altered binding affinity of
the SAA proteins for HDL and that the association between
SAA1/2 genetic variants and CVD may be modified by HDL.
Table 3. Association of SAA1 and SAA2 SNPs with HDL.
Mean IMT (cm) ± SD Model 1{ Model 21
SNP
Wild/Rare
Allele
Homozygous
for Rare Allele Heterozygous
Homozygous
for Wild Allele P (Rec*) P (Dom{) P (Add ) P (Rec*) P (Dom{) P(Add )
rs12218 T/C 1.2560.32 1.2960.31 1.4560.45 0.076 ,0.001 ,0.001 0.065 0.006 0.011
rs2229338 A/G 1.3960.36 1.4160.38 1.4160.39 0.132 0.669 0.678 0.213 0.373 0.179
rs1059559 T/C 1.4460.27 1.4160.30 1.4160.41 0.179 0.306 0.364 0.387 0.128 0.689
rs2468844 A/G 1.2860.35 1.3360.32 1.4460.40 0.036 ,0.001 ,0.001 0.067 ,0.001 0.004
1analysis of covariance adjusted for sex and age;
{Unadjusted model;
*recessive model;
{dominant model;
additive model.
doi:10.1371/journal.pone.0013997.t003
Table 4. Association of SAA1 and SAA2 SNPs with IMT.
Mean IMT (cm) ± SD Model 1{ Model 21
SNP
Wild/Rare
Allele
Homozygous
for Rare Allele Heterozygous
Homozygous
for Wild Allele P (Rec*) P (Dom{) P (Add ) P (Rec*) P (Dom{) P(Add )
rs12218 T/C 0.08660.04 0.08060.03 0.07060.03 0.068 ,0.001 0.003 0.077 0.008 ,0.001
rs2229338 A/G 0.08260.04 0.08060.03 0.07960.02 0.754 0.658 0.465 0.549 0.473 0.276
rs1059559 T/C 0.08160.03 0.07960.02 0.07860.02 0.259 0.147 0.324 0.437 0.256 0.423
rs2468844 A/G 0.08360.03 0.08160.03 0.08160.02 0.042 0.060 0.073 0.011 0.038 0.023
doi:10.1371/journal.pone.0013997.t004
SAA Gene and IMT
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employed the functional analysis of variation in SAA1/2, the
present study was in accordance with that of Carty et al. with
respect to the relationship between SAA1/2 and cIMT. Nonethe-
less, rs2468844 is a non-synonymous mutation and rs12218 is a
synonymous mutation. Whether both of these two polymorphisms
affect the stability or binding of the protein is not known.
Traditionally, silent SNPs have largely been assumed to not exert a
discernible effect on the function or phenotype of genes. However,
recent reports have changed this common viewpoint. Kimchi-
Sarfaty et al. [25] suggested that silent SNPs may affect the
translation rates of proteins, hence influencing the folding and
activity of proteins. Therefore, silent SNPs that do not change the
coding sequence of the protein may contribute to altered gene
function. Whether the silent SNPs in the SAA gene can affect its
function is unclear, but merits further investigation.
In conclusion, the polymorphisms of SAA1/2 gene were
associated with cIMT in a large cohort of healthy subjects. This
relationship was independent of serum levels of HDL and other
determinants of CVD risk. Our observations require further
research, but support the notion that the SAA gene directly
influences carotid IMT.
Methods
Ethical approval of the study protocol
This study was approved by the Ethics Committee of the First
Affiliated Hospital of Xinjiang Medical University (Xinjiang,
China). It was conducted according to the standards of the
Declaration of Helsinki. Written informed consent was obtained
from all participants.
Subjects
The CRS is a prospective, observational cohort study designed
to investigate the prevalence, incidence, and risk factors for CVDs
and to determine the genetic and environmental contributions to
atherosclerosis, CAD and cerebral infarction in the Han, Uygur,
and Kazakh population in the Xinjiang province of west China.
The CRS involves 14 618 Chinese people (5 757 Hans, 4 767
Uygurs, and 4 094 Kazakhs) aged $35 years recruited from seven
cities in Xinjiang province: Urumqi, Kelamayi, Hetian, Zhaosu,
Fukang, Tulufan, and Fuhai.
Collection of baseline data began in June 2007 and was
completed in March 2010. Of 14 618 subjects, 2 318 Han
participants were initially screened for the present study and
excluded (n=205) if: systolic and diastolic blood pressure (BP) was
$140/90 mmHg; fasting plasma glucose $7.0 mmol/L; total
cholesterol $7.8 mmol/L; triglycerides $2.0 mmol/L or had
electrocardiography (ECG) abnormalities and carotid artery
plaques. The final study number was 2113, of which 1914
consented to providing blood samples for DNA analysis. The
analysis presented in the present study was based on 1914 subjects
(849 men; 1065 women) who had passed the eligibility criteria and
had complete data on SAA1/2 genotypes.
Biological and lifestyle measurements
Height and body weight were measured as described previously
[26], Sitting blood pressure was measured thrice over 10 min and
the median value used in the statistical analysis. The status of
smoking and drinking was self-reported using a questionnaire as
described previously [27,28]. Two tubes (one containing ethyl-
enediamine tetra-acetic acid (EDTA) and the other not containing
an anticoagulant agent) were used for collecting blood samples
after the patient had fasted. The collected samples were separated
into plasma, serum and blood cells (including leukocytes) and
stored at 280uC for the analysis of routine blood chemistry and
DNA extraction. Samples were transported on dry ice at
prearranged intervals to laboratories. We measured the serum
concentration of total cholesterol, triglyceride, blood urea nitrogen
(BUN), creatinine (Cr), LDL, HDL, uric acid and fasting glucose
using equipment for chemical analysis (Dimension AR/AVL
Clinical Chemistry System, Newark, NJ, USA) employed by the
Clinical Laboratory Department of the First Affiliated Hospital of
Xinjiang Medical University.
Carotid ultrasonography
Ultrasonographic evaluation using a 7.5 MHz linear type B-
mode probe (Siemens, Berlin, Germany) was undertaken by a
specialist to evaluate sclerotic lesions of the common carotid
arteries on a day close to the day of blood biochemistry analysis
(within 2 days). Details of the procedure are described elsewhere
[29].
Reproducibility study
A reproducibility study was conducted. Two hundred and ten
subjects underwent two ultrasound examinations by two sonogra-
phers during the same visit; the sonographers were blinded to the
study protocol. The mean absolute difference and correlation
coefficient between repeated examinations of IMT of the common
carotid artery were 0.07mm and 0.84, respectively. For carotid
plaques, the Kappa coefficient for agreement between the two
examinations was 0.86.
Table 5. Interaction of SAA1 and SAA2 on IMT.
Source Type III Sum of Squares df Mean Square F P
Corrected Model 0.140
a 26 0.005 39.271 ,0.001
rs12218 0.007 2 0.003 25.040 ,0.001
rs2229338 6.005610
26 2 3.003610
26 0.022 0.978
rs1059559 1.859610
24 2 9.294610
25 0.679 0.507
rs2468844 0.001 2 0.001 5.001 0.007
rs12218 * rs2468844 0.012 4 0.003 22.125 ,0.001
rs2229338 * rs2468844 0.002 2 0.001 7.342 0.001
rs1059559* rs2468844 4.404610
24 4 1.101610
24 0.804 0.523
aR Squared=0.352 (Adjusted R Squared=0.343).
doi:10.1371/journal.pone.0013997.t005
SAA Gene and IMT
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There are 115 and 76 SNPs for the human SAA1 and SAA2
genes, respectively, listed in the National Center for Biotechnology
Information SNP database (http://www.ncbi.nlm.nih.gov/SNP). It
has been observed that adjacent SNPs are often highly correlated.
To reduce genotyping cost, many algorithms have been developed
to select a smallest set of SNPs such that all the other SNPs can be
inferred from them. The selected SNPs are called tag SNPs [30].
We selected the tag SNPs of SAA1 and SAA2 gene on the
International HapMap Project website using phase I & II database
(http://www.hapmap.org/). We obtained two tag SNPs (rs12218
and rs2468844 for the SAA1 and SAA2 genes) spanning the coding
region of ,4k bi nSAA1a n d,3k bi nSAA2 for Chinese Han
subjects using minor allele frequency (MAF) $0.05 and linkage
disequilibrium patterns withr
2$0.8as a cutoff.Because rs12218 is a
synonymous mutation, we selected two additional non-synonymous
mutations (rs2229338, rs1059559) across exon 4 of the SAA1 gene
for our analysis. Therefore, in the present study, four SNPs of the
SAA1 and SAA2 genewereselected forgenotype detection.Genomic
DNA was extracted from peripheral blood leukocytes using a DNA
extraction Kit (Beijing Bioteke Company Limited, Beijing, China).
Genotyping was confirmed by polymerase chain reaction (PCR)-
restriction fragment length polymorphism (RFLP) analysis. The
primers of these four SNPs were designed by use of Primer Premier
5.0. Their synthesis was undertaken by Shanghai Genery Biological
Technology Company Limited (Shanghai, China). The primer pair
sequences, annealing temperatures, and restriction enzymes for the
four SNPs are detailed in Table 6. Digestion of restriction enzymes
was according to manufacturer’s instructions. To ensure the results
to be verified, we used sequenced genomic DNAs as positive
controls in our assays.
Quality control
Of the genotyped samples, 10% were duplicated and there was
at least one positive and one negative control per 96-well DNA
plate in our assays. The accuracy of the genotyping was
determined by genotype concordance between duplicate samples.
We obtained 100% concordance between the genotyped duplicate
samples for each of the SNPs. The genotyping success rate for each
SNP was .98%.
Statistical analyses
All analyses were carried out using SPSS version 17.0 (SPSS
Inc., Chicago, IL, USA). The Hardy-Weinberg equilibrium was
assessed using chi-square analysis. Mean values of IMT between
the right and left common carotid artery were used in all analyses.
These values were normally distributed, so the original values were
used for analyses. General linear model analysis was undertaken to
test for associations between SNP genotypes and IMT and HDL
level after adjusting for confounding variables. Single-SNP effects
with continuous variables were analyzed using linear regression
using three models. These were the additive (common allele
homozygotes coded as 1, heterozygotes as 2, and recessive allele
homozygotes as 3); dominant (common allele homozygotes coded
as 1 and heterozygotes and recessive allele homozygotesas 2); and
recessive (common allele homozygotes and heterozygotes coded as
1 and recessive allele homozygotes as 2) models. Normality was
assessed by plotting the residuals. To analyze the interaction
between SAA1 and SAA2 on IMT, we used the two-way ANOVA
method. To assess the association of each SNP with HDL level
and IMT, we used a Bonferroni correction to control for the
number of variants tested; this was 4, so the probability value,
0.0125, was considered to be significant.
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